Adrestia Therapeutics
Flavius Alecsa started working as a Scientist at Horizon Discovery in January 2020 and held that position until February 2022. In February 2022, Flavius Alecsa joined Adrestia Therapeutics as a Scientist.
Flavius Alecsa pursued their education at the University of Essex from 2014 to 2017, where they obtained a Bachelor of Science (BS) degree in Biology/Biological Sciences. Following that, they continued their academic journey at the same university from 2018 to 2019, completing their Master of Science (MSc) degree in Molecular Medicine.
Adrestia Therapeutics
Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.